clinical trial · NCT05744713
An Observational Study of Patients With Chronic Liver Disease
Target PharmaSolutions, Inc.·—·enrolling by invitation·n = 500,000
Chronic Liver DiseaseCirrhosisObservational
brief summary
TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
started
Feb 19, 2024
primary completion
Dec 31, 2037
completion
Dec 31, 2037
last updated
Mar 3, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol